Cancer
Hpa16–24 (HLA-A*02:01) LLLGPLGPL
Product number: EP11231_1
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
The peptide Hpa16–24 (HLA-A*02:01) with the amino acid sequence LLLGPLGPL is a linear peptidic epitope (epitope ID 2150640) studied as part of Heparanase (UniProt:Q9Y251) from Homo sapiens (human).
Hpa16–24 (HLA-A*02:01) has been studied for immune reactivity in publications and has been tested in T cell assays.
TechData
| Sequence: | LLLGPLGPL |
| Gene: | HPSE |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Heparanase |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | Flow Cytometry, Immunohistochemistry |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |